Total Payments
$17,319
2024 Payments
$1,148
Companies
44
Transactions
449
Medicare Patients
5,009
Medicare Billing
$536,852
Payment Breakdown by Category
Food & Beverage$12,487 (72.1%)
Travel$4,346 (25.1%)
Education$403.09 (2.3%)
Consulting$83.57 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,487 | 427 | 72.1% |
| Travel and Lodging | $4,346 | 14 | 25.1% |
| Education | $403.09 | 7 | 2.3% |
| Consulting Fee | $83.57 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,960 | 34 | $0 (2020) |
| Edwards Lifesciences Corporation | $2,768 | 25 | $0 (2022) |
| Boston Scientific Corporation | $2,139 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,680 | 56 | $0 (2024) |
| Amgen Inc. | $952.47 | 47 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $870.65 | 47 | $0 (2024) |
| Cook Incorporated | $829.60 | 10 | $0 (2017) |
| Merck Sharp & Dohme LLC | $599.06 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $589.65 | 37 | $0 (2024) |
| Abbott Laboratories | $559.59 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,148 | 49 | Merck Sharp & Dohme LLC ($177.92) |
| 2023 | $1,172 | 55 | Amgen Inc. ($234.71) |
| 2022 | $942.52 | 47 | Merck Sharp & Dohme LLC ($170.54) |
| 2021 | $714.48 | 45 | AstraZeneca Pharmaceuticals LP ($114.74) |
| 2020 | $622.24 | 36 | Amgen Inc. ($148.30) |
| 2019 | $879.05 | 49 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($190.82) |
| 2018 | $3,484 | 57 | Medtronic Vascular, Inc. ($2,127) |
| 2017 | $8,358 | 111 | Edwards Lifesciences Corporation ($2,725) |
All Payment Transactions
449 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: ACCOLADE_CRM | ||||||
| 12/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/14/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.70 | General |
| 11/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $20.45 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $29.49 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: General - Therapies_CRM | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.08 | General |
| 08/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: General - Tachy_CRM | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.03 | General |
| 07/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.92 | General |
| Category: Cardiovascular | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2024 | BIOTRONIK INC. | Rivacor 7 DR-T (Device) | Food and Beverage | In-kind items and services | $87.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,027 | 1,355 | $388,974 | $101,090 |
| 2022 | 19 | 1,316 | 1,809 | $642,097 | $149,744 |
| 2021 | 21 | 1,353 | 1,785 | $575,488 | $142,847 |
| 2020 | 19 | 1,313 | 1,763 | $612,317 | $143,170 |
Total Patients
5,009
Total Services
6,712
Medicare Billing
$536,852
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 291 | $85,230 | $24,110 | 28.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 121 | $34,300 | $11,060 | 32.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 150 | $27,972 | $9,187 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 79 | $34,862 | $8,943 | 25.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 47 | 47 | $32,594 | $6,769 | 20.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 55 | $19,373 | $5,555 | 28.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 99 | 104 | $26,156 | $5,411 | 20.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 41 | $22,730 | $5,248 | 23.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 13 | 13 | $16,754 | $4,111 | 24.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 22 | $21,991 | $4,039 | 18.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $12,392 | $3,827 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,722 | $3,380 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 41 | $9,694 | $2,555 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 199 | 221 | $10,577 | $2,131 | 20.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 13 | 52 | $10,681 | $2,085 | 19.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 12 | 12 | $9,326 | $2,060 | 22.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 30 | 30 | $3,294 | $286.10 | 8.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 11 | 11 | $1,078 | $221.80 | 20.6% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 13 | 13 | $1,248 | $110.87 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 234 | 364 | $139,048 | $31,104 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 115 | 169 | $90,753 | $22,200 | 24.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 95 | 95 | $54,910 | $14,113 | 25.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 168 | $50,232 | $13,166 | 26.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 36 | 36 | $41,472 | $11,089 | 26.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 68 | 70 | $42,630 | $9,921 | 23.3% |
About Daniel Ong
Daniel Ong is a Internal Medicine healthcare provider based in Mesquite, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1427292705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Ong has received a total of $17,319 in payments from pharmaceutical and medical device companies, with $1,148 received in 2024. These payments were reported across 449 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($12,487).
As a Medicare-enrolled provider, Ong has provided services to 5,009 Medicare beneficiaries, totaling 6,712 services with total Medicare billing of $536,852. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Student in an Organized Health Care Education/Training Program
- Location Mesquite, TX
- Active Since 04/30/2009
- Last Updated 04/26/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427292705
Products in Payments
- Resolute (Device) $2,042
- WATCHMAN (Device) $1,321
- LifeVest (Device) $870.65
- BRILINTA (Drug) $774.53
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $753.21
- CoreValve Evolut (Device) $739.68
- Cook Medical Zilver PTX (Device) $672.28
- VERQUVO (Drug) $584.45
- ELIQUIS (Drug) $553.59
- Repatha (Biological) $508.90
- FARXIGA (Drug) $450.87
- Corlanor (Drug) $443.57
- ENTRESTO (Drug) $417.16
- ELCAELCA X-80 (Device) $259.27
- GENERAL - STENTS (Device) $243.59
- Xience Alpine cornary stent system (Device) $211.12
- JARDIANCE (Drug) $198.05
- CAMZYOS (Drug) $196.19
- Vascepa (Drug) $176.30
- XARELTO (Drug) $168.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mesquite
Sumana Gangi, M.d, M.D
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Salma Saiger, M.d, M.D
Internal Medicine — Payments: $196,369
Internal Medicine $196,369
Suthee Thumasathit, Md, MD
Internal Medicine — Payments: $28,543
Internal Medicine $28,543
Shalini Paturi, M.d, M.D
Internal Medicine — Payments: $12,267
Internal Medicine $12,267
Anita Tharian, Do, DO
Internal Medicine — Payments: $11,424
Internal Medicine $11,424
Dr. Sreedevi Guttikonda, Mbbs, MBBS
Internal Medicine — Payments: $8,813
Internal Medicine $8,813